APA

Kharitonenkov A., Beals J. M., Micanovic R., Strifler B. A., Rathnachalam R., Wroblewski V. J., Li S., Koester A., Ford A. M., Coskun T., Dunbar J. D., Cheng C. C., Frye C. C., Bumol T. F. & Moller D. E. (20131227). Rational design of a fibroblast growth factor 21-based clinical candidate, LY2405319. : PloS one.

Chicago

Kharitonenkov Alexei, Beals John M, Micanovic Radmila, Strifler Beth A, Rathnachalam Radhakrishnan, Wroblewski Victor J, Li Shun, Koester Anja, Ford Amy M, Coskun Tamer, Dunbar James D, Cheng Christine C, Frye Christopher C, Bumol Thomas F and Moller David E. 20131227. Rational design of a fibroblast growth factor 21-based clinical candidate, LY2405319. : PloS one.

Harvard

Kharitonenkov A., Beals J. M., Micanovic R., Strifler B. A., Rathnachalam R., Wroblewski V. J., Li S., Koester A., Ford A. M., Coskun T., Dunbar J. D., Cheng C. C., Frye C. C., Bumol T. F. and Moller D. E. (20131227). Rational design of a fibroblast growth factor 21-based clinical candidate, LY2405319. : PloS one.

MLA

Kharitonenkov Alexei, Beals John M, Micanovic Radmila, Strifler Beth A, Rathnachalam Radhakrishnan, Wroblewski Victor J, Li Shun, Koester Anja, Ford Amy M, Coskun Tamer, Dunbar James D, Cheng Christine C, Frye Christopher C, Bumol Thomas F and Moller David E. Rational design of a fibroblast growth factor 21-based clinical candidate, LY2405319. : PloS one. 20131227.